Phase 2/3 trial of molnupiravir for treatment of Covid-19 in nonhospitalized adults
Y Caraco, GE Crofoot, PA Moncada… - NEJM …, 2022 - evidence.nejm.org
Background Safe and effective oral treatments are needed to improve clinical outcomes for
nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small …
nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small …
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults
Y Caraco, GE Crofoot, PA Moncada… - NEJM …, 2022 - pubmed.ncbi.nlm.nih.gov
Molnupiravir in Nonhospitalized Patients Molnupiravir induces viral mutations to a threshold
beyond which Covid-19 cannot replicate. For nonhospitalized adults with mild-to-moderate …
beyond which Covid-19 cannot replicate. For nonhospitalized adults with mild-to-moderate …
[引用][C] Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults
Y Caraco, GE Crofoot, PA Moncada, AN Galustyan… - NEJM Evidence, 2022 - cir.nii.ac.jp
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML][HTML] Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults
Y Caraco, GE Crofoot, PA Moncada… - NEJM …, 2021 - evidence.nejm.org
Background Safe and effective oral treatments are needed to improve clinical outcomes for
nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small …
nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small …
[PDF][PDF] Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults
Y Caraco, GE Crofoot, PA Moncada, AN Galustyan… - scholar.archive.org
BACKGROUND Safe and effective oral treatments are needed to improve clinical outcomes
for nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small …
for nonhospitalized patients with Covid-19. Molnupiravir is an orally administered, small …
Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults.
Y Caraco, GE Crofoot, PA Moncada, AN Galustyan… - NEJM …, 2021 - europepmc.org
Molnupiravir in Nonhospitalized Patients Molnupiravir induces viral mutations to a threshold
beyond which Covid-19 cannot replicate. For nonhospitalized adults with mild-to-moderate …
beyond which Covid-19 cannot replicate. For nonhospitalized adults with mild-to-moderate …